Gene · 5209
Papers3,123
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,123
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives. | Mol Cancer | 2024 | 38262996 | PubTator, text mining | PubMed |
| Role of Elevated Serum TGF-β1 and the Common Promoter TGFB1-509C/T Polymorphism in the Development and Progression of Primary Glial Tumors and Brain Metastases. | Medicina (Kaunas) | 2024 | 38256406 | PubTator, text mining | PubMed |
| The TGF-β Family in Glioblastoma. | Int J Mol Sci | 2024 | 38256140 | PubTator, text mining | PubMed |
| Focus on Mitochondrial Respiratory Chain: Potential Therapeutic Target for Chronic Renal Failure. | Int J Mol Sci | 2024 | 38256023 | PubTator, text mining | PubMed |
| Implications of siRNA Therapy in Bone Health: Silencing Communicates. | Biomedicines | 2024 | 38255196 | PubTator, text mining | PubMed |
| Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes. | Mol Cancer | 2024 | 38254110 | PubTator, text mining | PubMed |
| The Apelin/APJ System: A Potential Therapeutic Target for Sepsis. | J Inflamm Res | 2024 | 38250143 | PubTator, text mining | PubMed |
| Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis. | J Neuroinflammation | 2024 | 38243312 | PubTator, text mining | PubMed |
| M6A methylation of FKFB3 reduced pyroptosis of gastric cancer by NLRP3. | Anticancer Drugs | 2024 | 38241195 | PubTator, text mining | PubMed |
| The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming. | Cancer Cell Int | 2024 | 38238756 | PubTator, text mining | PubMed |
| HP promotes neutrophil inflammatory activation by regulating PFKFB2 in the glycolytic metabolism of sepsis. | PLoS One | 2024 | 38227599 | PubTator, text mining | PubMed |
| Ginsenoside Rg3 overcomes tamoxifen resistance through inhibiting glycolysis in breast cancer cells. | Cell Biol Int | 2024 | 38225685 | PubTator, text mining | PubMed |
| Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges. | Technol Cancer Res Treat | 2024 | 38225190 | PubTator, text mining | PubMed |
| Drug-repurposing by virtual and experimental screening of PFKFB3 inhibitors for pancreatic cancer therapy. | Eur J Pharmacol | 2024 | 38220139 | PubTator, text mining | PubMed |
| Binding Free Energy Calculation Based on the Fragment Molecular Orbital Method and Its Application in Designing Novel SHP-2 Allosteric Inhibitors. | Int J Mol Sci | 2024 | 38203841 | PubTator, text mining | PubMed |
| Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis. | J Transl Med | 2024 | 38200582 | PubTator, text mining | PubMed |
| Local and dynamic regulation of neuronal glycolysis in vivo. | Proc Natl Acad Sci U S A | 2024 | 38198527 | PubTator, text mining | PubMed |
| Using meta-analysis and machine learning to investigate the transcriptional response of immune cells to Leishmania infection. | PLoS Negl Trop Dis | 2024 | 38190401 | PubTator, text mining | PubMed |
| Role of long non-coding RNAs in metabolic reprogramming of gastrointestinal cancer cells. | Cancer Cell Int | 2024 | 38184562 | PubTator, text mining | PubMed |
| RORα inhibits gastric cancer proliferation through attenuating G6PD and PFKFB3 induced glycolytic activity. | Cancer Cell Int | 2024 | 38184549 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5209/papers?page=17